Stay updated on Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page’s displayed revision/build number was updated from v3.5.2 to v3.5.3 in just the release/version footer, without altering study information such as eligibility, treatment arms, or study outcomes.SummaryDifference0.0%

- Check16 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Differentiated Thyroid Carcinoma to the list of eligible tumor types for the study.SummaryDifference0.0%

- Check45 days agoChange DetectedHepatocellular carcinoma was added to the list of conditions and the location label was updated from Napoli, Italy to Naples, Italy (80131).SummaryDifference0.1%

- Check59 days agoChange DetectedRevision metadata updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check81 days agoChange DetectedGastric cancer was added to the list of included conditions. The page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib Combo With Atezolizumab in Solid Tumors Clinical Trial page.